These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37207861)

  • 1. Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer.
    Patel H; Palekar S; Patel A; Patel K
    Int J Pharm; 2023 Jun; 641():123056. PubMed ID: 37207861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot-melt extrusion based sustained release ibrutinib delivery system: An inhibitor of Bruton's Tyrosine Kinase (BTK).
    Alshahrouri B; Yang F; Schwing Q; Dürig T; Fassihi R
    Int J Pharm; 2021 Sep; 607():120981. PubMed ID: 34371149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon-targeted delivery of niclosamide from solid dispersion employing a pH-dependent polymer via hotmelt extrusion for the treatment of ulcerative colitis in mice.
    Arjun S; Kulhari U; Padakanti AP; Sahu BD; Chella N
    J Drug Target; 2024 Dec; 32(2):186-199. PubMed ID: 38133596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.
    Kallakunta VR; Sarabu S; Dudhipala N; Janga KY; Bandari S; Zhang F; Repka MA
    Eur J Pharm Biopharm; 2021 Nov; 168():184-194. PubMed ID: 34464695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hot-melt extruded hydroxypropyl methylcellulose acetate succinate based amorphous solid dispersions: Impact of polymeric combinations on supersaturation kinetics and dissolution performance.
    Butreddy A; Sarabu S; Almutairi M; Ajjarapu S; Kolimi P; Bandari S; Repka MA
    Int J Pharm; 2022 Mar; 615():121471. PubMed ID: 35041915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
    Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
    J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
    Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
    J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs.
    Boel E; Smeets A; Vergaelen M; De la Rosa VR; Hoogenboom R; Van den Mooter G
    Eur J Pharm Biopharm; 2019 Nov; 144():79-90. PubMed ID: 31499162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of in vitro dissolution conditions for the in vivo predictability of an amorphous solid dispersion containing a pH-sensitive carrier.
    Wendelboe J; Knopp MM; Khan F; Chourak N; Rades T; Holm R
    Int J Pharm; 2017 Oct; 531(1):324-331. PubMed ID: 28827200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailoring supersaturation from amorphous solid dispersions.
    Li N; Taylor LS
    J Control Release; 2018 Jun; 279():114-125. PubMed ID: 29654798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
    Feng J; Xu L; Gao R; Luo Y; Tang X
    Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the dissolution properties of celecoxib melt extrudates: understanding the role of polymer type and concentration in stabilizing supersaturated drug concentrations.
    Abu-Diak OA; Jones DS; Andrews GP
    Mol Pharm; 2011 Aug; 8(4):1362-71. PubMed ID: 21696180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B; Liu S; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.